These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 18034870)

  • 1. Diversity in fibroblast growth factor receptor 1 regulation: learning from the investigation of Kallmann syndrome.
    Kim SH; Hu Y; Cadman S; Bouloux P
    J Neuroendocrinol; 2008 Feb; 20(2):141-63. PubMed ID: 18034870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insights in FGFR1 regulation: lessons from Kallmann syndrome.
    Hu Y; Bouloux PM
    Trends Endocrinol Metab; 2010 Jun; 21(6):385-93. PubMed ID: 20117945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked GnRH deficiency: role of KAL-1 mutations in GnRH deficiency.
    Hu Y; Bouloux PM
    Mol Cell Endocrinol; 2011 Oct; 346(1-2):13-20. PubMed ID: 21497178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-talk of anosmin-1, the protein implicated in X-linked Kallmann's syndrome, with heparan sulphate and urokinase-type plasminogen activator.
    Hu Y; González-Martínez D; Kim SH; Bouloux PM
    Biochem J; 2004 Dec; 384(Pt 3):495-505. PubMed ID: 15324302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Molecular genetics of Kallmann syndrome: an update].
    Fu C; Feng Z; Liu RZ
    Zhonghua Nan Ke Xue; 2011 Apr; 17(4):361-5. PubMed ID: 21548217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of disease: Insights into X-linked and autosomal-dominant Kallmann syndrome.
    Tsai PS; Gill JC
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):160-71. PubMed ID: 16932275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The genetics of hypogonadotropic hypogonadism.
    Bhagavath B; Layman LC
    Semin Reprod Med; 2007 Jul; 25(4):272-86. PubMed ID: 17594608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular pathogenesis of Kallmann's syndrome.
    Cadman SM; Kim SH; Hu Y; González-Martínez D; Bouloux PM
    Horm Res; 2007; 67(5):231-42. PubMed ID: 17191030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [GnRH deficiency: new insights from genetics].
    Kottler ML; Hamel A; Malville E; Richard N
    J Soc Biol; 2004; 198(1):80-7. PubMed ID: 15146960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kallmann syndrome.
    Dodé C; Hardelin JP
    Eur J Hum Genet; 2009 Feb; 17(2):139-46. PubMed ID: 18985070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated gonadotropic deficiency with and without anosmia: a developmental defect or a neuroendocrine regulation abnormality of the gonadotropic axis.
    de Roux N
    Horm Res; 2005; 64 Suppl 2():48-55. PubMed ID: 16286771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cysteine-rich region and the whey acidic protein domain are essential for anosmin-1 biological functions.
    Esteban PF; Murcia-Belmonte V; García-González D; de Castro F
    J Neurochem; 2013 Mar; 124(5):708-20. PubMed ID: 23189990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical assessment and molecular analysis of GnRHR and KAL1 genes in males with idiopathic hypogonadotrophic hypogonadism.
    Versiani BR; Trarbach E; Koenigkam-Santos M; Dos Santos AC; Elias LL; Moreira AC; Latronico AC; de Castro M
    Clin Endocrinol (Oxf); 2007 Feb; 66(2):173-9. PubMed ID: 17223984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2).
    Albuisson J; Pêcheux C; Carel JC; Lacombe D; Leheup B; Lapuzina P; Bouchard P; Legius E; Matthijs G; Wasniewska M; Delpech M; Young J; Hardelin JP; Dodé C
    Hum Mutat; 2005 Jan; 25(1):98-9. PubMed ID: 15605412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anosmin 1 Interacts with the Prokineticin Receptor 2 In Vitro Indicating a Molecular Link Between Both Proteins in the Pathogenesis of Kallmann Syndrome.
    Murcia-Belmonte V; Astillero-López V; Esteban PF
    Protein Pept Lett; 2016; 23(7):650-5. PubMed ID: 27184500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kallmann's syndrome, a neuronal migration defect.
    Cariboni A; Maggi R
    Cell Mol Life Sci; 2006 Nov; 63(21):2512-26. PubMed ID: 16952059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The recent genetics of hypogonadotrophic hypogonadism - novel insights and new questions.
    Semple RK; Topaloglu AK
    Clin Endocrinol (Oxf); 2010 Apr; 72(4):427-35. PubMed ID: 19719764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anosmin-1 modulates fibroblast growth factor receptor 1 signaling in human gonadotropin-releasing hormone olfactory neuroblasts through a heparan sulfate-dependent mechanism.
    González-Martínez D; Kim SH; Hu Y; Guimond S; Schofield J; Winyard P; Vannelli GB; Turnbull J; Bouloux PM
    J Neurosci; 2004 Nov; 24(46):10384-92. PubMed ID: 15548653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.